Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
about
Development of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusMiddle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlCoronaviruses and the human airway: a universal system for virus-host interaction studiesAnimal models of Middle East respiratory syndrome coronavirus infectionMolecular aspects of MERS-CoV.Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored VaccinesRecombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Self-disseminating vaccines for emerging infectious diseasesMiddle East respiratory syndrome vaccines.Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines.Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.Vaccines for the prevention against the threat of MERS-CoV.Middle East respiratory syndrome: current status and future prospects for vaccine development.Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.MERS-coronavirus: From discovery to intervention.Middle East respiratory syndrome coronavirus: five years later.ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia.An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.MERS vaccines advance, but will humans or camels get the jab?Middle East respiratory syndrome coronavirus: review of the current situation in the world.MERS-CoV: Understanding the Latest Human Coronavirus Threat.Lectin Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein Elimination.Aktueller Überblick zum MERS-Virus
P2860
Q26700054-A4A57951-031C-48E0-9F85-5C475D108B80Q26796501-14410F90-4A5A-49D4-9FAD-2C0778FF4FFAQ28075580-43D27313-4418-4BDF-9BB3-34F3A42E144BQ28086778-F10006B3-E62D-4F65-9006-8949E75C4738Q30234479-570ABB0E-DA84-451D-B58A-713FF8636459Q30382230-8CD5F55F-01CD-4246-A685-8EC0E4DB04FEQ30400066-7840F27B-2844-4F30-AA46-538CAAB3C15DQ35928588-9A8CB0F2-10A0-48D1-8F3F-D65F1D2D7A85Q36252666-6CCEEBFC-3199-450B-95AD-2D6E9CE343F9Q36518965-AC044809-DF2C-4F17-AE08-7662B456A657Q37143501-7424D939-CF21-4343-8463-AD33106C57C2Q37153663-FDB20E62-74B6-4378-972F-7746E89D94D7Q37169882-0B5E8802-DBB7-452F-83EC-FFB02FFC2536Q37560824-29065CBE-FF38-4213-B061-FDEDD2E1794CQ38156536-A463F16E-C3C6-480C-A230-C4A65618D8AEQ38778044-968FB479-8D96-468D-8B2D-98128F4610ADQ38959242-6D949BAC-97A7-43CC-9E04-E5F53388BE55Q38992327-38E91363-83D6-4562-A7C2-0830D23C9F0BQ39102732-E1E6C4BB-5504-4792-9BA7-03FE5BE11D30Q39374922-763EE00F-89B8-4BDF-9D3E-8DE6C930A9D6Q40085786-3401E55E-21B8-4AC5-AC10-4F22317E26D1Q40173497-AB3DFF2A-9641-4F51-BD17-89740F3B47A5Q40215096-BD301FA4-67E6-4821-B445-01104CE5C22EQ40428932-4392B380-599D-4136-8490-708DA84818FEQ40867301-D5969580-CDB2-48C7-A5F7-EA9894036E89Q46258141-25226D38-A544-48E5-AD8A-BFBABD214DD3Q47132991-105D22A4-C9CE-482C-8FD2-FD3CBE48E414Q47607374-D58EC8AD-7B6E-4216-B680-6EB673324A83Q50954130-87F92DA5-D9D4-40D5-AFB0-346DE0F062D3Q51799184-35D220A6-EA44-41C3-A1D1-3868675FAB06Q53701486-9FC19714-BE0A-495E-8F12-C5BE3DFA31E2Q54227404-8D023595-7FE6-4007-BA8C-E0D7D90BC9ADQ55109705-FA6B15BD-7C27-453B-9755-0A27F66C1412
P2860
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Protective Efficacy of Recombi ...... Coronavirus Spike Glycoprotein
@en
type
label
Protective Efficacy of Recombi ...... Coronavirus Spike Glycoprotein
@en
prefLabel
Protective Efficacy of Recombi ...... Coronavirus Spike Glycoprotein
@en
P2093
P2860
P356
P1433
P1476
Protective Efficacy of Recombi ...... Coronavirus Spike Glycoprotein
@en
P2093
Alexandra Kupke
Asisa Volz
Christin Becker
Hosam Shams-Eldin
Jörg Schmidt
Markus Eickmann
Stephan Becker
Sylvia Jany
P2860
P304
P356
10.1128/JVI.00614-15
P407
P577
2015-05-27T00:00:00Z